Cited by 222Neuropeptides and Animal PhysiologyStress Responses and CortisolNeuroendocrine regulation and behavior

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

Liebsch, Gudrun, Landgraf, Rainer, Gerstberger, Rüdiger, Probst, J.Christopher, Wotjak, Carsten T., Engelmann, Mario, Holsboer, Florian, Montkowski, Alexandra·1995·Regulatory Peptides

DOI 10.1016/0167-0115(95)00099-w

Open this paper in CoChat — free account

Abstract

We studied the role of central amygdala CRH receptors in behavioral responses to an anxiogenic stimulus. An antisense oligodeoxynucleotide corresponding to the rat CRH1 receptor mRNA was infused chronically into the central amygdaloid nucleus of male rats via osmotic minipumps (0.25 micrograms/0.5 microliters/h). Control groups received infusions of either a scrambled sequence oligodeoxynucleotide or vehicle. On the 4th day of treatment, rats were subjected to 10 min of social defeat and immediately afterwards tested on the elevated plus-maze. Antisense oligodeoxynucleotide-treated rats spent significantly more time exploring the open arms of the plus-maze than scrambled sequence- and vehicle-treated animals, both of which did not differ from each other. The social discrimination test, on the other hand, revealed no difference in juvenile recognition abilities among the treatment groups. Using in situ hybridization and receptor autoradiography, we were not able to detect clear signals of CRH1 receptor mRNA and CRH binding sites in the central amygdaloid nucleus of either group, confirming the reportedly low expression and density of CRH receptors in this brain area. The present data support the view that CRH receptors in the central nucleus of the amygdala are involved in the mediation and expression of anxiety-related behavior, but simultaneously raise questions as to the mechanisms of antisense oligodeoxynucleotide action.

Integrity signals

Registry

Crossref · 10.1016/0167-0115(95)00099-w

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
The role of the amygdala in fear and anxiety
Davis, M. (1992) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.15.030192.002033 · Cited by 2,357
Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?
Dunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,147
Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.
Lovenberg, T. W., Liaw, C. W., Grigoriadis, D. E., Clevenger, W., Chalmers, D. T., Souza, E. B. D., & Oltersdorf, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.836 · Cited by 846
Emotional memory systems in the brain
LeDoux, J. E. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90091-4 · Cited by 812
Neurotransmission in the rat amygdala related to fear and anxiety
Davis, M., Rainnie, D., & Cassell, M. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90106-6 · Cited by 771
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. L. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534

Show all 51 references

Research works printed but not linked: 2

Pich, 1992, Stress-induced release of corticotropin-releasing factor in the amygdala measured by in vivo microdialysis, Soc. Neurosci. Abstr., 18, 535
Neumann, 1994, An oxytocin (OXT) antisense oligonucleotide (AS) infused into the supraoptic nucleus (SON) rapidly alters the excitability of OXT neurons in lactating rats, Soc. Neurosci. Abstr., 20, 1538

Sorted by citations

Items 101–200 of 222

Defensive Behavioral Strategies and Enhanced State Anxiety during Chronic Subordinate Colony Housing Are Accompanied by Reduced Hypothalamic Vasopressin, But Not Oxytocin, Expression
Reber, S. O., & Neumann, I. D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.003 · Cited by 66
Assessment of neuroleptic-like properties of progesterone
Rupprecht, R., Koch, M., Montkowski, A., Lancel, M., Faulhaber, J., Harting, J., & Spanagel, R. (1999) · Psychopharmacology · doi:10.1007/s002130050916 · Cited by 62
“Therefore, we investigated the e¤ects of progesterone in the elevated plus-maze test in combination with a preceding social defeat paradigm that together are more sensitive to the anxiolytic e¤ects of drugs than the elevated plus-maze test alone (Liebsch et al. 1995).”
BackgroundMethodInfluentialSelf-citation
Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders
Keck, M. E., Ohl, F., Holsboer, F., & Müller, M. B. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.003 · Cited by 64
Self-citation
Corticotropin‐releasing Factor in the Caudal Pontine Reticular Nucleus Mediates the Expression of Fear‐potentiated Startle in the Rat
Fendt, M., Koch, M., & Schnitzler, H. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01400.x · Cited by 61
Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system
Hashimoto, K., Nishiyama, M., Tanaka, Y., Noguchi, T., Asaba, K., Pournajafi‐Nazarloo, H., Nishioka, T., & Makino, S. (2004) · Peptides · doi:10.1016/j.peptides.2004.05.024 · Cited by 60
Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress
Hammack, S. E., Pepin, J. L., DesMarteau, J. S., Watkins, L. R., & Maier, S. F. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00133-5 · Cited by 60
“[17]), which appear to be R1 mediated [18].”
Background
An Anxiolytic Role for CRF Receptor Type 1 in the Globus Pallidus
Sztainberg, Y., Kuperman, Y., Justice, N. J., & Chen, A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3087-11.2011 · Cited by 60
“CRFR1 downregulation in the amygdala, either by antisense oligonucleotides (Liebsch et al., 1995) or by lentiviral-mediated small interference RNA (Sztainberg et al., 2010), results in an anxiolytic-like effect.”
Background
Advances in Understanding the Pharmacological Properties of Antisense Oligonucleotides
Crooke, S. T. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60136-2 · Cited by 58
Sex differences in rats: Effects of chronic stress on sympathetic system and anxiety
Renard, G. M., Suárez, M. M., Levin, G. M., & Rivarola, M. A. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.05.003 · Cited by 56
“[19], the apparatus consisted of a plus-shaped platform elevated 50 cm from the floor.”
Background
Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder
Kellner, M. B., Yassouridis, A., Jahn, H., & Wiedemann, K. (1997) · Psychopharmacology · doi:10.1007/s002130050371 · Cited by 54
“Complementarily, animal experiments show anxiolytic e¤ects of anti-CRH and anti-CRH receptor targeting (Skutella et al. 1994; Liebsch et al. 1995).”
Background
Neuropeptide Y alters sedation through a hypothalamic Y1‐mediated mechanism
Naveilhan, P., Canals, J. M., Valjakka, A., Vartiainen, J., Arenas, E., & Ernfors, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01601.x · Cited by 54
“Administration of CRH and transgenic mice overexpressing CRH gives exaggerated anxiety-related behaviour, while suppressing CRH, by antisense technologies or by blocking CRH-receptor synthesis, produces anxiolytic effects (Skutella et al., 1994; Stenzel-Poore et al., 1994; Liebsch et al., 1995).”
Background
Sex differences in prenatally programmed anxiety behaviour in rats: Differential corticotropin-releasing hormone receptor mRNA expression in the amygdaloid complex
Brunton, P. J., Donadio, M. V. F., & Russell, J. A. (2011) · Stress · doi:10.3109/10253890.2011.604750 · Cited by 53
“…antisense nucleotides into the CeA (which expresses CRH-R1, but not CRH-R2) has anxiolytic actions in socially defeated rats (Heinrichs et al. 1992; Liebsch et al. 1995), in ethanol-dependent (Rassnick et al. 1993) or opiatedependent (Heinrichs et al. 1995) rats and in rats previously exposed to…”
Background
A CRH1 Antagonist into the Amygdala of Mice Prevents Defeat‐Induced Defensive Behavior
Robison, C. L., Meyerhoff, J. L., Saviolakis, G. A., CHEN, W. K., Rice, K. C., & Lumley, L. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.052 · Cited by 53
Corticotropin-releasing factor type-1 receptor antagonists: The next class of antidepressants?
Nielsen, D. M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.06.003 · Cited by 50
Amygdala protein kinase C epsilon regulates corticotropin‐releasing factor and anxiety‐like behavior
Lesscher, H. M. B., McMahon, T., Lasek, A. W., Chou, W.-H., Connolly, J., Kharazia, V., & Messing, R. O. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00356.x · Cited by 47
“Infusion of CRF antagonists or CRF1-receptor antisense oligonucleotides into the amygdala reduces stress-induced, anxiety-like behavior in rats (Heinrichs et al. 1992; Liebsch et al. 1995).”
Background
Opposite effects of stress on effortful motivation in high and low anxiety are mediated by CRHR1 in the VTA
Zalachoras, I., Astori, S., Meijer, M., Grosse, J., Zanoletti, O., de Suduiraut, I. G., Deussing, J. M., & Sandi, C. (2022) · Science Advances · doi:10.1126/sciadv.abj9019 · Cited by 51
Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances
Wood, S. K., & Woods, J. H. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1401 · Cited by 48
“Another likely CNS site of vagal regulation is the central nucleus of the amygdala (CeA); although not completely understood, cortical signals, for example, activate the central nucleus of the amygdala [31] , which project to both the NTS, as well as the DMV directly [41] , stimulating vagal efferent communication wit…”
BackgroundInfluential
Urocortin 1, Urocortin 3/Stresscopin, and Corticotropin-Releasing Factor Receptors in Human Adrenal and Its Disorders
Fukuda, T., Takahashi, K., Suzuki, T., Saruta, M., Watanabe, M., Nakata, T., & Sasano, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0090 · Cited by 47
Deletion of CRH From GABAergic Forebrain Neurons Promotes Stress Resilience and Dampens Stress-Induced Changes in Neuronal Activity
Dedic, N., Kühne, C., Gomes, K. S., Hartmann, J., Ressler, K. J., Schmidt, M. V., & Deussing, J. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00986 · Cited by 46
Targeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior
Contarino, A., & Gold, L. H. (2002) · Neuropeptides · doi:10.1054/npep.2002.0899 · Cited by 44
Corticotropin-releasing factor type II (CRF₂) receptors in the bed nucleus of the stria terminalis modulate conditioned defeat in Syrian hamsters (Mesocricetus auratus).
Cooper, M. A., & Huhman, K. L. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.4.1042 · Cited by 42
Neuropeptides in Anxiety Modulation
Landgraf, R. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_12 · Cited by 41
Self-citation
Heteroatom-linked indanylpyrazines are corticotropin releasing factor type-1 receptor antagonists
Corbett, J. W., Rauckhorst, M. R., Qian, F., Hoffman, R. L., Knauer, C. S., & Fitzgerald, L. W. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.008 · Cited by 41
Acute stress imposed during adolescence yields heightened anxiety in Sprague Dawley rats that persists into adulthood: Sex differences and potential involvement of the Medial Amygdala
Lovelock, D. F., & Deak, T. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146392 · Cited by 41
“CRH, thought to be a mediator of anxiety-like behaviors in the amygdala (Liebsch et al., 1995), was increased specifically in the MeA.”
Background
Hypothalamic-Pituitary-Adrenocortical System and Mood Disorders: Highlights from Mutant Mice
Müller, M. B., Uhr, M., Holsboer, F., & Keck, M. E. (2004) · Neuroendocrinology · doi:10.1159/000076041 · Cited by 40
Self-citation
Genetically engineered mice for studies of stress-related clinical conditions
Müller, M. B., & Keck, M. E. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00049-8 · Cited by 38
The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat.
Harro, J., Tõnissaar, M., & Eller, M. (2001) · Neuropeptides · doi:10.1054/npep.2001.0851 · Cited by 42
NMDAR2B tyrosine phosphorylation regulates anxiety-like behavior and CRF expression in the amygdala
Delawary, M., Tezuka, T., Kiyama, Y., Yokoyama, K., Inoue, T., Hattori, S., Hashimoto, R., Umemori, H., Manabe, T., Yamamoto, T. S., et al. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-37 · Cited by 36
“CRF in the amygdala contributes to anxiety because injection of CRF antagonists or CRF1 receptor antisense oligonucleotides into the amygdala reduces anxiety-like behavior in rats [19,20].”
Background
Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats
Zelena, D., Filaretova, L. P., Mergl, Z., Barna, I., Tóth, Z., & Makara, G. B. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00118.2005 · Cited by 36
Atrial natriuretic hormone in lactate-induced panic attacks: mode of release and endocrine and pathophysiological consequences
Kellner, M. B., Knaudt, K., Jahn, H., Holsboer, F., & Wiedemann, K. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00034-4 · Cited by 36
Self-citation
Endocrine and behavioral effects of neuromedin S
Jászberényi, M., Bagosi, Z., Thurzó, B., Földesi, I., & Telegdy, G. (2007) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.08.002 · Cited by 36
Psychiatric Disorders - Trends and Developments
Uehara, T. (2011) · InTech eBooks · doi:10.5772/2330 · Cited by 36
Naloxone-induced changes in tachykinin NK3 receptor modulation of experimental anxiety in mice
Ribeiro, S. J., & de Lima, T. C. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00880-5 · Cited by 35
Involvement of plasma atrial natriuretic peptide in protracted alcohol withdrawal
Kiefer, F., Andersohn, F., Jahn, H., Wolf, K., Raedler, T. J., & Wiedemann, K. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.0_011.x · Cited by 34
“In this context it could be demonstrated that ANP exerts its effects not only as a peripheral physiological antagonist of CRH effects (7), but also acts directly within the central nervous system (CNS), counteracting centrally mediated anxiogenic effects of CRH (8).”
Background
Neuropeptides and Anxiety-Related Behavior.
Landgraf, R. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.517 · Cited by 34
Self-citation
In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001
Chaki, S., Okuyama, S., Nakazato, A., Kumagai, T., Okubo, T., Ikeda, Y., Oshida, Y., Hamajima, Y., & Tomisawa, K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00120-x · Cited by 34
Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge
Nguyen, N. K., Keck, M. E., Hetzenauer, A., Thoeringer, C. K., Wurst, W., Deussing, J. M., Holsboer, F., Müller, M. B., & Singewald, N. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0513-1 · Cited by 32
“…of CRF-R1 antisense oligodeoxynucleotides, has been shown to produce anxiolytic-like effects in different behavioral tests, including the elevated plus maze (EPM) test, the open-field and the defensive withdrawal tests (Heinrichs et al. 1997; Liebsch et al. 1995, 1999; Skutella et al. 1998).”
BackgroundSelf-citation
Prospects for antidepressant drug discovery
Holsboer, F. (2001) · Biological Psychology · doi:10.1016/s0301-0511(01)00089-8 · Cited by 32
Self-citation
CRHR1 Antagonists as Novel Treatment Strategies
Holsboer, F. (2001) · CNS Spectrums · doi:10.1017/s1092852900002133 · Cited by 30
Self-citation
Endocrine, behavioral and autonomic effects of neuropeptide AF
Jászberényi, M., Bagosi, Z., Thurzó, B., Földesi, I., Szabó, G., & Telegdy, G. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.02.006 · Cited by 30
“The antalarmin-evoked attenuation of the EPM response reinforced the finding of previous publications, according to which CRH release can facilitate stress-related behavior, and decrease the time spent in the open arms during the EPM test (Liebsch et al., 1995).”
Result
Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder
Hodges, L. M., Weissman, M. M., Haghighi, F. G., Costa, R., Bravo, O., Evgrafov, O. V., Knowles, J. A., Fyer, A. J., & Hamilton, S. P. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30773 · Cited by 28
“Knockdown of CRHR1 by antisense mRNA reduces anxiety that is provoked by stress testing paradigms or CRH administration [Skutella et al., 1994a,b, 1998; Liebsch et al., 1995, 1999; Heinrichs et al., 1997].”
Method
Mouse Mutants for the Study of Corticotropin‐Releasing Hormone Receptor Function: Development of Novel Treatment Strategies for Mood Disorders
Keck, M. E., HOLSBOER, F., & Müller, M. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.055 · Cited by 28
Self-citation
Rodent anxiety and kindling of the central amygdala and nucleus basalis
Adamec, R., & Shallow, T. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00250-x · Cited by 27
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression
Wichniak, A., Brünner, H., Ising, M., Gil, F. P., Holsboer, F., & Frieß, E. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.11.004 · Cited by 27
Self-citation
Corticotropin-releasing factor antagonists, binding-protein and receptors: implications for central nervous system disorders
Heinrichs, S. C., & Souza, E. B. D. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0042 · Cited by 26
Central vasopressin administration failed to influence anxiety behavior after pinealectomy in rats
Appenrodt, E., & Schwarzberg, H. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00237-1 · Cited by 24
Neuroendocrine and behavioral effects of antisense oligonucleotides
Landgraf, R., Naruo, T., Vecsernyés, M., & Neumann, I. D. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370326 · Cited by 24
Self-citation
Toward a better understanding of the central consequences of intestinal inflammation
Nyuyki, K. D., & Pittman, Q. J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12935 · Cited by 26
Microinfusion of a Corticotrophin‐Releasing Hormone Receptor 1 Antisense Oligodeoxynucleotide into the Dorsal Hippocampus Attenuates Stress Responses at Specific Times After Stress Exposure
Kozlovsky, N., Zohar, J., Kaplan, Z., & Cohen, H. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02267.x · Cited by 23
Functional, endogenously expressed corticotropin‐releasing factor receptor type 1 (CRF1) and CRF1receptor mRNA expression in human neuroblastoma SH‐SY5Y cells
Schoeffter, P., Feuerbach, D., Bobimac, I., Gazi, L., & Longato, R. (1999) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1999.tb00007.x · Cited by 23
The effect of short moderate stress on the midbrain corticotropin-releasing factor system in a macaque model of functional hypothalamic amenorrhea
Bethea, C. L., Phu, K., Reddy, A. P., & Cameron, J. L. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.052 · Cited by 23
Mouse Models of Depression
Dedic, N., Sandra, M., & Jan, M. (2011) · InTech eBooks · doi:10.5772/27498 · Cited by 27
“So far, most of the results provide evidence that amygdalar CRHR1 is responsible for the observed phenotypes (Liebsch et al., 1995;Sztainberg et al., 2010).”
Amygdaloid Corticotropin-releasing Factor is Involved in the Anxiolytic Effect of Acupuncture during Ethanol Withdrawal in Rats
Zhao, Z., Jin, X., Wu, Y., Yang, X., Xu, Y., Jiang, J. Z., Kim, S. C., Lee, B. H., Yang, C. H., & Zhao, R. (2013) · Journal of Acupuncture and Meridian Studies · doi:10.1016/j.jams.2013.01.017 · Cited by 22
“Pharmacological and genetic manipulation of amygda-loid CRF can regulate anxiety-like behavior in rodents [15,16].”
CRF and CRF Receptors
Radulović, J., Blank, T., Eckart, K., Radulović, M., Stiedl, O., & Spiess, J. (1999) · Results and problems in cell differentiation · doi:10.1007/978-3-540-49421-8_4 · Cited by 22
Brain as a Unique Antisense Environment
Szklarczyk, A., & Kaczmarek, L. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.105 · Cited by 22
Emotion
Davis, M., & Lang, P. J. (2003) · Wiley eBooks · doi:10.1002/0471264385.wei0315 · Cited by 22
Ovarian steroid regulation of the midbrain corticotropin releasing factor and urocortin systems in macaques
Sänchez, R. L., Reddy, A. P., & Bethea, C. L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.059 · Cited by 21
Sociality and the telencephalic distribution of corticotrophin‐releasing factor, urocortin 3, and binding sites for CRF type 1 and type 2 receptors: A comparative study of eusocial naked mole‐rats and solitary Cape mole‐rats
Coen, C. W., Κalamatianos, T., Oosthuizen, M. K., Poorun, R., Faulkes, C. G., & Bennett, N. C. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23796 · Cited by 21
“Chronic local infusion of a CRF1 antisense oligonucleotide reduces anxiety-related behavior following social defeat (Liebsch et al., 1995).”
Background
CRF type 1 receptors of the medial amygdala modulate inhibitory avoidance responses in the elevated T-maze
Vicentini, J. E., Céspedes, I. C., Nascimento, J. O. G., Bittencourt, J. C., & Viana, M. D. B. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.01.004 · Cited by 20
“CRFR1 antisense nucleotides in to the cen tral amygdala decreases social defeat behavior and contextual freezing (Heinrichs et al., 1992; Liebsch et al., 1995) in ethanol-dependent ( Rassn ick et al.”
Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala
Scholl, J. L., Vuong, S. M., & Forster, G. L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.07.008 · Cited by 20
Biological intersection of sex, age, and environment in the corticotropin releasing factor (CRF) system and alcohol
Agoglia, A. E., Crofton, E. J., & Herman, M. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108045 · Cited by 20
Inverse effects of lipopolysaccharides on anxiety in pregnant mice and their offspring.
Solati, J., Kleehaupt, E., Kratz, O., Moll, G., & Golub, Y. (2015) · Physiology and Behavior · doi:10.1016/j.physbeh.2014.10.016 · Cited by 18
Sex, social status, and CRF receptor densities in naked mole‐rats
Beery, A. K., Bicks, L. K., Mooney, S. J., Goodwin, N. L., & Holmes, M. M. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23834 · Cited by 18
“Expression of social defeatinduced anxiety is dependent on activation of CRF1 receptors, as antisense mRNA targeting this receptor blocks social defeat-induced anxiety behavior in an elevated plus maze (Liebsch et al., 1995).”
Background
Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB)
Yang, M., Farrokhi, C. B., Vasconcellos, A., Blanchard, R. J., & Blanchard, D. C. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.013 · Cited by 18
“Down-regulation of CRF1 by antisense oligodeoxynucleotide led to attenuated anxiety-like behaviors in rats [28],[34].”
Background
Developmental and withdrawal effects of adolescent AAS exposure on the glutamatergic system in hamsters.
Carrillo, M., Ricci, L. A., & Melloni, R. H. (2011) · Behavioral Neuroscience · doi:10.1037/a0023475 · Cited by 17
“Given that in various animal models the CeA has been implicated in the modulation of anxiety behavior (Kalin, Shelton, & Davidson, 2004; Liebsch et al., 1995; Pandey, Roy, & Zhang, 2003) it is possible that alterations in the glutamatergic system within the CeA regulate this anxiogenic behavioral…”
Background
Amitriptyline Treatment Under Chronic Stress Conditions: Effect on Circulating Catecholamines and Anxiety in Early Maternally Separated Rats
Cotella, E. M., Lascano, I. M., Levin, G. M., & Suárez, M. M. (2009) · International Journal of Neuroscience · doi:10.1080/00207450802330611 · Cited by 17
“As described in detail by Liebsch et al. (1995), the apparatus consisted of a plus-shaped platform elevated 50 cm from the floor.”
Background
Involvement of NK1 receptors in metabolic stress markers after the central administration of substance P
Mello, D. M. D. S., Marcinichen, D. R., Madruga, D., Branco, R., Paschoalini, M. A., & de Lima, T. C. M. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.04.010 · Cited by 17
The Impact of Atrial Natriuretic Peptide on Anxiety, Stress and Craving in Patients with Alcohol Dependence
Koopmann, A., Leménager, T., Wolf, N. D., Reinhard, I., Hermann, D., Koch, J., Wiedemann, K., & Kiefer, F. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt160 · Cited by 17
Ovarian Steroid Treatment Decreases Corticotropin-Releasing Hormone (CRH) mRNA and Protein in the Hypothalamic Paraventricular Nucleus of Ovariectomized Monkeys
Bethea, C. L., & Centeno, M. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301442 · Cited by 17
“Within the limbic system there is evidence that the CRH system modulates behavioral traits such as locomotor activity, sleep, addictive behavior, and in particular, anxiety related behavior (Dunn and Berridge, 1990; Liebsch et al, 1995).”
Background
Aggression and anxiety in adolescent AAS-treated hamsters: A role for 5HT3 receptors
Morrison, T. R., Ricci, L. A., & Melloni, R. H. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.05.001 · Cited by 17
“…et al., 1986; Vinkers et al., 2010), while also playing a role in the expression of anxiety-related behaviors (Davis, 1998; Kalin et al., 2004; Liebsch et al., 1995; Pandey et al., 2003; Pratt, 1992), and are considered a critical part of the extended amygdala, regulating emotional behaviors…”
Background
Chapter 5. Corticotropin-Releasing Hormone (CRH) Receptors and the Discovery of Selective Non-Peptide CRH1 Antagonists
Gilligan, P. J., Hartig, P. R., Robertson, D. W., & Zaczek, R. C. (1997) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61463-3 · Cited by 17
Angiotensin II AT1 receptor antagonists inhibit the angiotensin‐CRF‐AVP axis and are potentially useful for the treatment of stress‐related and mood disorders
Saavedra, J. M., & Pavel, J. (2005) · Drug Development Research · doi:10.1002/ddr.20027 · Cited by 16
Antisense oligonucleotides in neuroendocrinology: Enthusiasm and frustration
Neumann, I. D. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00107-6 · Cited by 17
Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in rats
Engelmann, M., Landgraf, R., Lörscher, P., Conzelmann, C., Probst, J. C., Holsboer, F., & Reul, J. M. H. M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00702-x · Cited by 16
Self-citation
Stress-axis, coping and dementia: gene-manipulation studies
Heinrichs, S. C. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01335-8 · Cited by 16
Anxiogenic-Like Effect of Corticotropin-Releasing Factor Receptor 2 Antisense Oligonucleotides Infused into Rat Brain
Isogawa, K., Akiyoshi, J., Tsutsumi, T., Kodama, K., Horinouti, Y., & Nagayama, H. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103174004 · Cited by 15
“…both intracerebroventricular and intra-central nucleus of amygdala infusions of CRF-R1 antisense oligonucleotides antagonized the increase of anxietyrelated behaviour induced by intracerebroventricular injection of CRF or by social defeat, respectively (Liebsch et al., 1995; Skutella et al., 1998).”
Background
Cortagine infused into the medial prefrontal cortex attenuates predator-induced defensive behaviors and Fos protein production in selective nuclei of the amygdala in male CD1 mice
Pentkowski, N. S., Tovote, P., Zavala, A. R., Litvin, Y., Blanchard, D. C., Spiess, J., & Blanchard, R. J. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.06.008 · Cited by 14
“…social interaction (Campbell et al., 2004) and rat exposure (RET; Tovote et al., 2010) tests, while inhibition by central administration of antisense oligodeoxynucleotides directed against CRF1 mRNA attenuates defensive behavior (Heinrichs et al., 1997; Liebsch et al., 1995; Skutella et al., 1998).”
The Role of the Anterodorsal Thalami Nuclei in the Regulation of Adrenal Medullary Function, Beta-adrenergic Cardiac Receptors and Anxiety Responses in Maternally Deprived Rats under Stressful Conditions
Suárez, M. M., Rivarola, M. A., Molina, S. M., Levin, G. M., Enders, J., & Paglini, P. A. (2004) · Stress · doi:10.1080/10253890400010705 · Cited by 14
“As described in detail by Liebsch et al. (1995), the apparatus consisted of a plus-shaped platform elevated 50 cm from the floor.”
Background
Natriuretic peptides and panic disorder: therapeutic prospects
Kellner, M. B., Jahn, H., & Wiedemann, K. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.3.381 · Cited by 13
Chapter 2. Recent Progress in Corticotropin-Releasing Factor Receptor Agents
McCarthy, J. R., Heinrichs, S. C., & Grigoriadis, D. E. (1999) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60564-3 · Cited by 13
Neuropeptide Regulation of Stress-Induced Behavior
Sztainberg, Y., & Chen, A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375097-6.10015-0 · Cited by 12
“Intra-CeA infusions of antisense oligodeoxynucleotides against CRFR1 reduce anxiety-like behavior in socially defeated rats.(97) Intra-BLA administration of astressin B, a CRFR1/2 antagonist, reverses the anxiogenic effects ofUcn1,(98)whereas intra-BLAadministration of the CRFR1-specific antagonist antalarmin prevents…”
Background
The impact of social defeat on basomedial amygdala neuronal activity in adult male rats.
Ritger, A. C., Stickling, C. P., & Ferrara, N. C. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114418 · Cited by 11
Reproductive Experience Alters Neural and Behavioural Responses to Acute Oestrogen Receptor α Activation
Byrnes, E. M., Casey, K. M., Carini, L. M., & Bridges, R. S. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12113 · Cited by 11
Transgenic Mouse Models: New Tools for Psychiatric Research
Holsboer, F. (1997) · The Neuroscientist · doi:10.1177/107385849700300514 · Cited by 11
Self-citation
Chapter 4.1 Peptide receptor ligands to treat anxiety disorders
Steckler, T. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00010-0 · Cited by 10
CRF antagonism within the ventral tegmental area but not the extended amygdala attenuates the anxiogenic effects of cocaine in rats
Ettenberg, A., Cotten, S. W., Brito, M. A., Klein, A. K., Ohana, T. A., Margolin, B. D., Wei, A., & Wenzel, J. M. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.10.002 · Cited by 9
“In contrast, antagonism of CRF function in the CeA or BNST has been reported to attenuate the anxiogenic response to bright light or the stress inherent to the social defeat test (de Jongh et al., 2003; Heinrichs et al., 1992; Liebsch et al., 1995; Swiergiel et al., 1993; Walker et al., 2009) and Erb and Stewart (1999…”
Background
Prior stress and vasopressin promote corticotropin-releasing factor inhibition of serotonin release in the central nucleus of the amygdala
Ronan, P. J., Korzan, W. J., Johnson, P. L., Lowry, C. A., Renner, K. J., & Summers, C. H. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1148292 · Cited by 7
“Antagonism of CRF receptors in the CeA or dRN reduces behavioral responses to stressors (Swiergiel et al., 1993; Liebsch et al., 1995; Hammack et al., 2003; Skorzewska et al., 2009), while increasing intra-CeA concentrations of GABA (Skorzewska et al.”
Background
Tianeptine Influence on Plasmatic Catecholamine Levels and Anxiety Index in Rats Under Variable Chronic Stress After Early Maternal Separation
Trujillo, V., Masseroni, M. L., Levin, G. M., & Suárez, M. M. (2009) · International Journal of Neuroscience · doi:10.1080/00207450802324713 · Cited by 7
“As described in detail by Liebsch et al. (1995), the apparatus consists of a plus-shaped platform elevated 50 cm from the floor.”
Background
CRF antagonists as novel treatment strategies for stress-related disorders
Steckler, T. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80065-3 · Cited by 7
Altered emotional behaviors in the diabetes mellitus OLETF type 1 congenic rat
Watanabe, A., Okuno, S., Okano, M., Jordan, S., Aihara, K., Watanabe, T., Yamasaki, Y., Kitagawa, H., Sugawara, K., & Kato, S. (2007) · Brain Research · doi:10.1016/j.brainres.2007.07.075 · Cited by 7
Amitriptyline: sex‐dependent effect on sympathetic response and anxiety in rats submitted to early maternal separation and variable chronic stress in adulthood
Luján, V. E. D., Castellanos, M. M., Levin, G. M., & Suárez, M. M. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2008.03.004 · Cited by 7
“As described in detail by Liebsch et al. (1995), the apparatus consisted of a plus-shaped platform elevated 50 cm from the floor.”
Background
Synthesis, in vitro biological investigation, and molecular dynamics simulations of thiazolopyrimidine based compounds as corticotrophin releasing factor receptor-1 antagonists
Elgiushy, H. R., Abou-Taleb, N. A., Holz, G. G., Chepurny, O. G., Pirmettis, I. C., Kakabakos, S. E., Karageorgos, V., Liapakis, G., Albohy, A., Abouzid, K. A. M., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105079 · Cited by 6
Chronic cortisol suppresses pituitary and hypothalamic peptide message expression in pigtailed macaques
Szot, P., Wilkinson, C. W., White, S. S., Leverenz, J. B., Greenup, J. L., Colasurdo, E. A., Peskind, E. R., & Raskind, M. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.030 · Cited by 6
Effects of Corticotropin-Releasing Factor on Circadian Locomotor Rhythm in the Golden Hamster
Seifritz, E. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00065-3 · Cited by 6
Maternal Separation and Lesion of Adtn Alters Anxiety And Adrenal Activity in Male Rats
Esquivel, B. B., Levin, G. M., Rivarola, M. A., & Suárez, M. M. (2009) · International Journal of Neuroscience · doi:10.1080/00207450902931847 · Cited by 6
“As described in detail by Liebsch et al. (1995), the apparatus consisted of a plusshaped platform elevated 50 cm from the floor.”
Background
Molekulare Mechanismen der Depressionstherapie
Holsboer, F. (1999) · Springer eBooks · doi:10.1007/978-3-662-07096-3_9 · Cited by 6
Self-citation
Neuroanatomical pathways underlying the effects of hypothalamo-hypophysial-adrenal hormones on exploratory activity
Lalonde, R., & Strazielle, C. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0075 · Cited by 4
“Likewise, subchronic infusion of antisense oligodeoxynucleotides against CRHR1 mRNA in the central nucleus of the amygdala increased open arm duration after resident intruder-induced stress relative to scrambled sequence oligodeoxynucleotide-treated rats and vehicle controls (Liebsch et al., 1995).”
Background
Rapid Onset of Antisense Effects: Evidence for A Close Link Between Gene Expression and Neuronal Activity
Neumann, I. D., & Pittman, Q. J. (1998) · Perspectives in antisense science · doi:10.1007/978-1-4615-4933-8_4 · Cited by 4
Mutagenesis and Knockout Models: Hypothalamic-Pituitary-Adrenocortical System
Keck, M. E., & Müller, M. B. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_4 · Cited by 4
Mediation of burn-induced hypermetabolism by CRF receptor-2 activity
Chance, W. T., Dayal, R., Friend, L. A., Thomas, I., & Sheriff, S. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.11.047 · Cited by 4

Authors: Liebsch, G., Landgraf, R., Gerstberger, R., Probst, J. C., Wotjak, C. T., Engelmann, M., Holsboer, F., & Montkowski, A.
Affiliations: Max Planck Institute of Psychiatry (DE)
Max Planck Society (DE)
Corresponding author: Montkowski, Alexandra
ORCID: Wotjak, Carsten T.
Engelmann, Mario
Venue: Regulatory Peptides
Publisher: Elsevier BV
Published: 1995-10
Volume: 59
Issue: 2
Pages: 229-239
ISSN: 0167-0115 (ISSN-L)
DOI: 10.1016/0167-0115(95)00099-w
OpenAlex: W1967569415
Cited by: 220
References: 51
Citations by year: 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 7 · 2014: 5 · 2013: 10 · 2012: 3
FWCI: 3.33
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Regulatory Peptides (publishedVersion)
PubMed (publishedVersion)
Max Planck Institute for Plasma Physics (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
Keywords: central amygdala, antisense oligodeoxynucleotides, anxiety-like behavior, social defeat, elevated plus maze, social discrimination, gene silencing
MeSH terms: Amygdala, Animals, Anxiety, Autoradiography, Base Sequence, Behavior, Animal, Discrimination Learning, Infusions, Parenteral, Functional Laterality, Male, Molecular Sequence Data, Social Behavior, Oligonucleotides, Antisense, Rats, Wistar, In Situ Hybridization, Receptors, Corticotropin-Releasing Hormone, Maze Learning, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks